Market Overview

Trade CNS stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
4/22/19Gabelli & Co.DowngradesBuyHold
2/21/19Keefe Bruyette & WoodsDowngradesMarket PerformUnderperform
1/25/19Keefe Bruyette & WoodsUpgradesUnderperformMarket Perform36.0
Show more Loading articles...

Earnings View Earnings

Q3 2019 EST Actual Surprise
EPS: 0.630 0.650 0.0200
Rev: 105.53M 104.97M -565.00K
Q4 2019 EST Actual Surprise
EPS: Expected
2020-01-22
Rev:

Company Profile

Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo